Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

A Study of ALS-008176 in Infants Hospitalized With RSV

ClinicalTrials.gov ID: NCT02202356

Public ClinicalTrials.gov record NCT02202356. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 1:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, 2-Part Study of Orally Administered ALS-008176 to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Dosing and Multiple Ascending Dosing in Infants Hospitalized With Respiratory Syncytial Virus (RSV) Infection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will assess the safety, tolerability, pharmacokinetics (PK) and anti-viral effect of single and multiple doses of ALS-008176 in infants hospitalized with respiratory syncytial virus (RSV)

Study identification

NCT ID
NCT02202356
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Alios Biopharma Inc.
Industry
Enrollment
183 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Up to 12 Months
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 23, 2014 (Actual)
Primary completion
Feb 15, 2018 (Actual)
Completion
Feb 15, 2018 (Actual)
Last update posted
Feb 3, 2025

2014 – 2018

United States locations

U.S. sites
17
U.S. states
13
U.S. cities
17
Facility City State ZIP Site status
Children's of Alabama Birmingham Alabama 35233 —
Arkansas Children's Hospital Research Institute Little Rock Arkansas 72202 —
Long Beach Memorial Medical Center/Miller Children's and Women's Hospital of Long Beach Long Beach California 90806 —
Children's Hospital of Orange County Orange California 92868 —
The University of California at San Diego San Diego California 92093 —
LSU Health Sciences Center Shreveport Louisiana 71103 —
Massachusetts General Hospital Boston Massachusetts 02114 —
The Children's Mercy Kansas City Missouri 64108 —
University of Rochester Rochester New York 14611 —
The University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599 —
Duke University Durham North Carolina 27708 —
The Research Institute at Nationwide Children's Hospital Columbus Ohio 43205 —
Children's Hospital/University of Tennessee Memphis Tennessee 38103 —
UT Southwestern Medical Center Dallas Texas 75390 —
Texas Children's Hospital/Baylor College of Medicine Houston Texas 77030 —
The University of Utah Salt Lake City Utah 84112 —
Seattle Children's Hospital Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 60 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02202356, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 3, 2025 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02202356 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →